Matthew Lang

Matthew Lang has an estimated net worth of $12.6 Million. This is based on reported shares across multiple companies, which include Myovant Sciences Ltd., Lyell Immunopharma, Inc., Metsera, Inc., and Structure Therapeutics Inc..

2020 was Matthew Lang's most active year for acquiring shares with 9 total transactions. Matthew Lang's most active month to acquire stocks was the month of July. 2020 was Matthew Lang's most active year for disposing of shares, totalling 15 transactions. Matthew Lang's most active month to dispose stocks was the month of July. 2021 saw Matthew Lang paying a total of $233,400.00 for 178,771 shares, this is the most they've acquired in one year. In 2021 Matthew Lang cashed out on 84,487 shares for a total of $1,248,140.54, their largest year based on trade value.